Cochrane Hypertension
@cochranehtn.bsky.social
Based @UBC, we prepare/maintain/disseminate #SysRevs of effects of healthcare interventions for high blood pressure.
hypertension.cochrane.org Newsltr: http://eepurl.com/G2yC1
hypertension.cochrane.org Newsltr: http://eepurl.com/G2yC1
Pinned
Pharmacotherapy for mild hypertension - Wang, D - 2025 | Cochrane Library
Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.
www.cochranelibrary.com
🆕 @cochrane.org Review update 🆕
Pharmacotherapy for mild hypertension www.cochranelibrary.com/cdsr/doi/10....
In ppl w/ mildly elevated blood pressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
Pharmacotherapy for mild hypertension www.cochranelibrary.com/cdsr/doi/10....
In ppl w/ mildly elevated blood pressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
October 15, 2025 at 3:56 PM
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
🆕Review update🆕
Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10....
In people with mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10....
In people with mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
October 15, 2025 at 3:55 PM
🆕Review update🆕
Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10....
In people with mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10....
In people with mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
🆕 @cochrane.org Review update 🆕
Pharmacotherapy for mild hypertension www.cochranelibrary.com/cdsr/doi/10....
In ppl w/ mildly elevated blood pressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
Pharmacotherapy for mild hypertension www.cochranelibrary.com/cdsr/doi/10....
In ppl w/ mildly elevated blood pressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
Pharmacotherapy for mild hypertension - Wang, D - 2025 | Cochrane Library
Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.
www.cochranelibrary.com
September 25, 2025 at 7:38 PM
🆕 @cochrane.org Review update 🆕
Pharmacotherapy for mild hypertension www.cochranelibrary.com/cdsr/doi/10....
In ppl w/ mildly elevated blood pressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
Pharmacotherapy for mild hypertension www.cochranelibrary.com/cdsr/doi/10....
In ppl w/ mildly elevated blood pressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD
#SystematicReview
Reposted by Cochrane Hypertension
Clearer, more consistent Cochrane reviews are coming.
From mid-November, we’re updating reporting formats to make reviews easier to use, more accessible, and more impactful.
🔗 www.cochrane.org/about-us/new...
From mid-November, we’re updating reporting formats to make reviews easier to use, more accessible, and more impactful.
🔗 www.cochrane.org/about-us/new...
September 23, 2025 at 11:01 AM
Clearer, more consistent Cochrane reviews are coming.
From mid-November, we’re updating reporting formats to make reviews easier to use, more accessible, and more impactful.
🔗 www.cochrane.org/about-us/new...
From mid-November, we’re updating reporting formats to make reviews easier to use, more accessible, and more impactful.
🔗 www.cochrane.org/about-us/new...
Reposted by Cochrane Hypertension
Too good to be true? Spotting problematic trials in systematic reviews | Online
🗓️ 26 February
This interactive webinar will introduce the INSPECT-SR tool by way of application to a published clinical trial.
🔗 evidencesynthesisireland.ie/conference/w...
🗓️ 26 February
This interactive webinar will introduce the INSPECT-SR tool by way of application to a published clinical trial.
🔗 evidencesynthesisireland.ie/conference/w...
Webinar: Dr Jack Wilkinson - Too good to be true? Spotting problematic trials in systematic reviews
To register, CLICK HERE Systematic reviews of randomized controlled trials (RCTs) aim to include all eligible
evidencesynthesisireland.ie
August 29, 2025 at 11:28 AM
Too good to be true? Spotting problematic trials in systematic reviews | Online
🗓️ 26 February
This interactive webinar will introduce the INSPECT-SR tool by way of application to a published clinical trial.
🔗 evidencesynthesisireland.ie/conference/w...
🗓️ 26 February
This interactive webinar will introduce the INSPECT-SR tool by way of application to a published clinical trial.
🔗 evidencesynthesisireland.ie/conference/w...
Reposted by Cochrane Hypertension
Getting involved in health research reviews: a course for the public | Online
🗓️ 15 September
Are you a patient, caregiver, or member of the public interested in contributing to health research? This 6-week, self-paced course from Cochrane Ireland is for you.
🔗 www.eventbrite.ie/e/getting-in...
🗓️ 15 September
Are you a patient, caregiver, or member of the public interested in contributing to health research? This 6-week, self-paced course from Cochrane Ireland is for you.
🔗 www.eventbrite.ie/e/getting-in...
Getting Involved in Health Research Reviews: A Course for the Public
Designed for the public and helps you build the knowledge and skills to contribute to research teams conducting health research reviews.
www.eventbrite.ie
August 29, 2025 at 11:28 AM
Getting involved in health research reviews: a course for the public | Online
🗓️ 15 September
Are you a patient, caregiver, or member of the public interested in contributing to health research? This 6-week, self-paced course from Cochrane Ireland is for you.
🔗 www.eventbrite.ie/e/getting-in...
🗓️ 15 September
Are you a patient, caregiver, or member of the public interested in contributing to health research? This 6-week, self-paced course from Cochrane Ireland is for you.
🔗 www.eventbrite.ie/e/getting-in...
Reposted by Cochrane Hypertension
📣 We're rounding up a few dates for your diary. Discover these events being run by our global network of Cochrane Groups – a thread 🧵
August 29, 2025 at 11:28 AM
📣 We're rounding up a few dates for your diary. Discover these events being run by our global network of Cochrane Groups – a thread 🧵
ICYMI - Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
September 2, 2025 at 5:51 PM
ICYMI - Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
June 10, 2025 at 8:11 PM
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Reposted by Cochrane Hypertension
Also check out our complementary #deprescribing resources to reduce potentially inappropriate medications found here:
deprescribing.org/resources/de...
deprescribing.org/resources/de...
Deprescribing Guidelines and Algorithms - Deprescribing.org
deprescribing.org
May 10, 2025 at 4:08 PM
Also check out our complementary #deprescribing resources to reduce potentially inappropriate medications found here:
deprescribing.org/resources/de...
deprescribing.org/resources/de...
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
May 12, 2025 at 6:09 PM
🚨ICYMI - Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
🆕 We've published a new Cochrane #SystematicReview protocol:
Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
doi.org/10.1002/1465...
Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
doi.org/10.1002/1465...
April 21, 2025 at 8:42 PM
🆕 We've published a new Cochrane #SystematicReview protocol:
Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
doi.org/10.1002/1465...
Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
doi.org/10.1002/1465...
Reposted by Cochrane Hypertension
SR & MA findings: very few (<10%) clinical trials report adverse drug withdrawal event (ADWE) following #deprescribing, and reporting methods are inconsistent.
Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
April 15, 2025 at 1:34 PM
SR & MA findings: very few (<10%) clinical trials report adverse drug withdrawal event (ADWE) following #deprescribing, and reporting methods are inconsistent.
Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
Reposted by Cochrane Hypertension
🚨 ICYMI - TI #BestEvidence webinar:
Dr. Josh Levin compares #PhysicalActivity to drugs for important clinical outcomes
ti.ubc.ca/drugevidence24
#DrugEvidence24 #exercise #MedEd
Dr. Josh Levin compares #PhysicalActivity to drugs for important clinical outcomes
ti.ubc.ca/drugevidence24
#DrugEvidence24 #exercise #MedEd
Dr. Josh Levin: Physical activity compared to drugs for important clinical outcomes.
YouTube video by Therapeutics Initiative
www.youtube.com
April 14, 2025 at 5:42 PM
🚨 ICYMI - TI #BestEvidence webinar:
Dr. Josh Levin compares #PhysicalActivity to drugs for important clinical outcomes
ti.ubc.ca/drugevidence24
#DrugEvidence24 #exercise #MedEd
Dr. Josh Levin compares #PhysicalActivity to drugs for important clinical outcomes
ti.ubc.ca/drugevidence24
#DrugEvidence24 #exercise #MedEd
Reposted by Cochrane Hypertension
ICYMI: #BestEvidence webinar recording
Debunking some of the hype in #hypertension
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on #antihypertensives
⏰ chronotherapy
💊 first line tx
🎯 BP targets
⚠️ tx efficacy + safety
#DrugEvidence24 #MedEd #medsafety
Debunking some of the hype in #hypertension
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on #antihypertensives
⏰ chronotherapy
💊 first line tx
🎯 BP targets
⚠️ tx efficacy + safety
#DrugEvidence24 #MedEd #medsafety
Dr. James (Jim) Wright: Debunking some of the hype In hypertension
YouTube video by Therapeutics Initiative
www.youtube.com
April 15, 2025 at 4:47 PM
ICYMI: #BestEvidence webinar recording
Debunking some of the hype in #hypertension
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on #antihypertensives
⏰ chronotherapy
💊 first line tx
🎯 BP targets
⚠️ tx efficacy + safety
#DrugEvidence24 #MedEd #medsafety
Debunking some of the hype in #hypertension
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on #antihypertensives
⏰ chronotherapy
💊 first line tx
🎯 BP targets
⚠️ tx efficacy + safety
#DrugEvidence24 #MedEd #medsafety
🚨Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
April 11, 2025 at 8:42 PM
🚨Updated Cochrane #SystematicReview:
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Withdrawal of antihypertensive drugs in older people 💊
doi.org/10.1002/1465...
"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"
#CochraneEvidence #bloodpressure #deprescribing
Reposted by Cochrane Hypertension
🧵 #ExercisePrescriptions
1/5 The TI’s Dr. Josh Levin asks:
Clinicians, can you help your patients be more active? 🏃🏾♀️🏊🏾♂️ 🚶🏾♂️
👉🏾Watch Dr. Levin’s presentation: www.youtube.com/watch?v=G5he...
#Exercise #prescribing #ExerciseRx
1/5 The TI’s Dr. Josh Levin asks:
Clinicians, can you help your patients be more active? 🏃🏾♀️🏊🏾♂️ 🚶🏾♂️
👉🏾Watch Dr. Levin’s presentation: www.youtube.com/watch?v=G5he...
#Exercise #prescribing #ExerciseRx
Dr. Josh Levin: Exercise prescriptions - Evidence and clinical applications
YouTube video by Therapeutics Initiative
www.youtube.com
April 11, 2025 at 6:06 PM
🧵 #ExercisePrescriptions
1/5 The TI’s Dr. Josh Levin asks:
Clinicians, can you help your patients be more active? 🏃🏾♀️🏊🏾♂️ 🚶🏾♂️
👉🏾Watch Dr. Levin’s presentation: www.youtube.com/watch?v=G5he...
#Exercise #prescribing #ExerciseRx
1/5 The TI’s Dr. Josh Levin asks:
Clinicians, can you help your patients be more active? 🏃🏾♀️🏊🏾♂️ 🚶🏾♂️
👉🏾Watch Dr. Levin’s presentation: www.youtube.com/watch?v=G5he...
#Exercise #prescribing #ExerciseRx
🆕 Cochrane #SystematicReview 🆕
Effect of adrenergic agonist oral #decongestants on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
Effect of adrenergic agonist oral #decongestants on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
April 1, 2025 at 3:52 PM
🆕 Cochrane #SystematicReview 🆕
Effect of adrenergic agonist oral #decongestants on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
Effect of adrenergic agonist oral #decongestants on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
🆕 Cochrane #SystematicReview 🆕
Effect of #amphetamines on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
Effect of #amphetamines on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
March 31, 2025 at 7:16 PM
🆕 Cochrane #SystematicReview 🆕
Effect of #amphetamines on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
Effect of #amphetamines on blood pressure:
www.cochranelibrary.com/cdsr/doi/10....
#CochraneEvidence #blogshot #bloodpressure
ICYMI - Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
March 24, 2025 at 4:36 PM
ICYMI - Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
🚨ICYMI - Cochrane #SystematicReview
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
March 12, 2025 at 6:29 PM
🚨ICYMI - Cochrane #SystematicReview
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/14651858.CD012570.pub2
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/14651858.CD012570.pub2
#CochraneEvidence #Blogshot
March 4, 2025 at 8:31 PM
Cochrane #SystematicReview 🎺
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/14651858.CD012570.pub2
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/14651858.CD012570.pub2
#CochraneEvidence #Blogshot
#BestEvidence webinar recording
Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on #antihypertensives:
⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety
#drugevidence24 #meded #medsafety
Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on #antihypertensives:
⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety
#drugevidence24 #meded #medsafety
Dr. James (Jim) Wright: Debunking some of the hype In hypertension
YouTube video by Therapeutics Initiative
youtu.be
March 4, 2025 at 8:07 PM
#BestEvidence webinar recording
Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on #antihypertensives:
⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety
#drugevidence24 #meded #medsafety
Debunking some of the hype in #Hypertension
ti.ubc.ca/drugevidence24
Dr. James Wright summarizes latest evidence on #antihypertensives:
⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety
#drugevidence24 #meded #medsafety
🎺 Cochrane #SystematicReview 🚨
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
tinyurl.com/renin-arb-htn
#CochraneEvidence #Blogshot @drotte.medsky.social @ciprian-jauca.bsky.social @amtejani.bsky.social
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
tinyurl.com/renin-arb-htn
#CochraneEvidence #Blogshot @drotte.medsky.social @ciprian-jauca.bsky.social @amtejani.bsky.social
February 28, 2025 at 7:25 PM
🎺 Cochrane #SystematicReview 🚨
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
tinyurl.com/renin-arb-htn
#CochraneEvidence #Blogshot @drotte.medsky.social @ciprian-jauca.bsky.social @amtejani.bsky.social
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
tinyurl.com/renin-arb-htn
#CochraneEvidence #Blogshot @drotte.medsky.social @ciprian-jauca.bsky.social @amtejani.bsky.social
🎺 Cochrane #SystematicReview 🚨
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
February 27, 2025 at 11:17 PM
🎺 Cochrane #SystematicReview 🚨
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot
Renin inhibitors versus angiotensin receptor blockers for primary #hypertension
doi.org/10.1002/1465...
#CochraneEvidence #Blogshot